Integra LifeSciences Holdings Corp.

Ms. Leonetti joined Integra in 1997 as Director of Marketing, was promoted to Vice President of Marketing in April 1999 , Senior Vice President of Global Marketing in May 2004 and Chief Marketing Officer in September 2007. Her responsibilities include marketing communications, corporate branding, sales operations, and customer service. In addition, Ms Leonetti is responsible for the sales activity of a direct sales team in Canada, Distributors in Asia and Latin America and Integra's Private Label business partners. From 1989 through 1997, Ms. Leonetti worked for Cabot Medical, which was later acquired by Circon Corporation, and held positions in sales, sales training, and marketing. Prior to her experience at Cabot-Circon, Ms. Leonetti completed fifteen years of clinical practice as a registered nurse at St. Christopher's Hospital for Children in Philadelphia. She received her Nursing degree from St. Joseph's Hospital School of Nursing and La Salle University.

Mr. Carlozzi joined Integra in March 2003 as Executive Vice President and Chief Operating Officer, responsible for the Company’s global marketing, sales, manufacturing, distribution, and R&D functions. Mr. Carlozzi had 20 years of high level management experience in the medical device industry prior to joining Integra. He was President, Chief Executive Officer and a director of Bionx Implants, a company focused on the development of novel biomaterial devices for various surgical specialties from 1999 to 2003. Prior to 1999, he held various management positions at Synthes North America, Acufex Microsurgical Inc. and Infusaid Inc. He received a BS degree in engineering and an MBA from Northeastern University. Mr. Carlozzi also serves on the Board of Directors for several privately held companies

John B. Henneman, III is Integra’s Executive Vice President, Finance and Administration and Chief Financial Officer. He is responsible for regulatory affairs, corporate quality systems, clinical affairs, clinical education, business development, human resources, the law department, investor relations and the Integra Medical Instrument Group. In addition, he is responsible for the Company’s finance department, including corporate controllership, financial reporting, budgeting, internal audit, tax, and treasury functions of the Company. Mr. Henneman has been our Executive Vice President and Chief Administrative Officer since February 2003 and was Acting Chief Financial Officer from September 6, 2007 until May 13, 2008. Mr. Henneman was our General Counsel from September 1998 until September 2000 and our Senior Vice President, Chief Administrative Officer and Secretary from September 2000 until February 2003. Prior to joining Integra in August 1998, Mr. Henneman served Neuromedical Systems, Inc., a public company developer and manufacturer of in vitro diagnostic equipment, in various capacities for more than four years. Mr. Henneman received an A.B. degree from Princeton University and a J.D. from the University of Michigan Law School.

Randy Gottlieb joined Integra as Vice President and Chief Information Officer in May 2004. Mr. Gottlieb is responsible for leading Integra's global information technology organization. Prior to Integra, he worked for Bristol-Myers Squibb for over 20 years. During that time, Mr. Gottlieb held positions of increasing responsibility, managing information technology functions in the corporate staff, international headquarters, U.K. and ConvaTec business units. Mr. Gottlieb received a bachelors degree in Psychology from SUNY Stony Brook and an MBA from Baruch College.

Simon J. Archibald, Ph.D., is the Chief Scientific Officer for Integra LifeSciences Corporation. Dr Archibald joined Integra in 1997 as Senior Director of Neurological Programs to oversee the clinical and commercial development of the NeuraGen™ Nerve Guide and to explore the development of a neurosurgical product line from the existing Integra collagen business and patent portfolio. In 1997, Dr. Archibald initiated and ran the program that produced the DuraGen® Dural Graft Matrix, for which he is a co-inventor. In 1999, he was promoted to Vice President of Research and Development for Integra NeuroSciences and in 2001 he was promoted to Vice President of Clinical Affairs. Previously Dr. Archibald was an Assistant Professor in the Department of Neurosurgery at Duke University Medical Center, to which he was appointed after completing Research Fellowships in Neuropathology and Neuroscience at Harvard Medical School. He graduated with a degree in Zoology from the University of Reading, UK, and has a Ph.D. in Biomedical Engineering from the University of North Staffordshire, UK.

Mr. Oti is Integra’s Senior Vice President of Global Operations. He is responsible for the company’s worldwide manufacturing, planning, distribution, repairs and service operations. He joined Integra in January 2008, and has extensive experience in the medical device industry. Prior to joining Integra, he spent 14 years with Johnson & Johnson where he held executive management and strategic leadership positions in worldwide operations, engineering and advanced manufacturing at the DePuy franchise. He received undergraduate and graduate degrees in Engineering from Western Michigan University and Case Western Reserve University respectively.

Mr. Bostjancic joined Integra in July 1999 as Director of Financial Reporting and was promoted to Vice President in January 2005. Mr. Bostjancic served as Integra’s Corporate Controller from December 2003 through June 2006. In July 2006, Mr. Bostjancic was named Vice President, Corporate Development and Investor Relations. In May 2008, Mr. Bostjancic was named Senior Vice President, Finance. His primary responsibilities include overseeing business processes, Oracle implementations, SOX remediation, M&A due diligence and integration, budgeting, and financial analysis at Integra. Mr. Bostjancic graduated from the College of New Jersey in 1993 with a BS in Accountancy and worked for five years at PricewaterhouseCoopers LLP in their audit practice and for one year at Merck & Co., Inc. in the Accounting Standards Group.

Ms. O'Grady has served Integra and its predecessor companies since 1985. Ms. O'Grady has worked in the areas of medical devices and collagen technology for over 20 years. Prior to joining Integra, Ms. O'Grady worked for Colla-Tec, Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson company, and was on the faculty of Boston University College of Nursing and Medical School. Ms. O'Grady led the team that obtained the FDA approval for INTEGRA¨ Dermal Regeneration Template, the first regenerative product approved by the FDA, and has led teams responsible for more than 500 FDA and international submissions. She received her B.S. degree from Marquette University and M.S.N. in Nursing from Boston University

JUDITH E. O GRADY is Integra s Senior Vice President of Regulatory Affairs, Quality Assurance and Clinical Affairs, and Corporate Compliance Officer. Ms. O Grady joined Integra in 1985. Ms. O Grady has worked in the areas of medical devices and collagen technology for over 20 years. Prior to joining Integra, Ms. O Grady worked for Colla-Tec, Inc., a Marion Merrell Dow Company. During her career she has held positions with Surgikos, a Johnson & Johnson Company, and was on the faculty of Boston University College of Nursing and Medical School. Ms. O Grady led the team that obtained the approval of the Food and Drug Administration ( FDA ) for INTEGRA Dermal Regeneration Template, the first regenerative product approved by the FDA, and has led teams responsible for approvals of the Company s other regenerative product lines as well as more than 600 FDA and international submissions. Ms. O Grady received a B.S. degree from Marquette University and M.S.N. in Nursing from Boston University.

Mr. Gorelick joined Integra as Vice President and General Counsel in 2000 and became Corporate Secretary in 2006. In March 2008 he was given additional responsibility for worldwide human resources. Prior to that, he spent four and a half years at Aventis Behring LLC, a global leader in biologics (plasma proteins) as Associate General Counsel, where his practice focused on technology licensing, strategic alliances, acquisitions and managing commercial litigation. Prior to that, Mr. Gorelick was an associate in the Business and Finance Section of Morgan, Lewis & Bockius LLP, in Philadelphia, where his practice concentrated on, among other things, transactions, corporate reorganizations and creditors' rights and secured transactions. Mr. Gorelick is a graduate of Princeton University and Boalt Hall School of Law, University of California at Berkeley

Ms. Davis joined Integra as Vice President, Human Resources in 2000. In March 2008, Ms. Davis was named Acting Chief Information Officer with responsibility for worldwide information technology. Previously, Ms. Davis held various positions in the insurance industry, including Chief Diversity Officer at Chubb Insurance, Vice President of Quality and Human Resources at General Reinsurance Corporation, and Director of Operations at Allstate Insurance Company. Ms. Davis received a B.S. in Business Administration from Lambuth University and an M.S. degree in Human Resource Development from American University.

Mr. Corbin joined Integra as Corporate Controller in 2006. He is responsible for overseeing the preparation of the financial statements, compliance with SEC and GAAP rules and regulations, financial audits and reviews and planning and executing improvements to the worldwide financial infrastructure of the organization. For more than fifteen years before Integra, Jerry held key finance positions in corporate accounting, sales and marketing and, most recently, research and development for sanofi-aventis and its predecessors. Prior to sanofi, he held management positions with Sigma-Aldrich Corporation and Edward D. Jones & Company. Jerry gained his initial auditing experience with Arthur Andersen & Company. Mr. Corbin holds a BS in Accounting from Illinois State University and is certified as a public accountant.

Ms. Platsis joined Integra in September 2003 as Director of Corporate Development, and was promoted to Vice President in May 2006. Her responsibilities include the identification and execution of acquisitions and strategic alliances. Prior to joining Integra, Ms. Platsis worked in the investment banking group at Merrill Lynch and practiced law in the Corporate Departments of Latham & Watkins and GoodSmith, Gregg & Unruh. Ms. Platsis received a B.A. degree in Economics from the University of Michigan, a J.D. from the University of Michigan Law School, and an M.B.A from the University of Chicago.

STUART M. ESSIG is Integra s President and Chief Executive Officer and a director. He joined Integra in December 1997. Before joining Integra, Mr. Essig supervised the medical technology practice at Goldman, Sachs & Co. as a managing director. Mr. Essig had ten years of broad health care experience at Goldman Sachs serving as a senior merger and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients. Mr. Essig also serves on the Board of Directors of St. Jude Medical Corporation and ADVAMED, the Advanced Medical Technology Association. From March 2005 until August 2008, he also served on the Board of Directors of Zimmer Holdings, Inc. Mr. Essig received an A.B. degree from the Woodrow Wilson School of Public and International Affairs at Princeton University and an M.B.A. and a Ph.D. degree in Financial Economics from the University of Chicago, Graduate School of Business. Mr. Essig is 47 years old.

Mr. Larkin joined Integra in January of 2000 as a Regional Sales Manager, has served as the National Sales Manager since 2003, was promoted to Vice President, North American Sales in 2005 and to President of the Integra NeuroSciences Division in 2007. His current responsibilities include executive oversight and divisional leadership of Integra's OrthoBiologics and NeuroSciences businesses. Mr. Larkin has 18 years of sales, sales management and executive management experience in the neuro medical device industry. Prior to joining Integra, he was the National Sales Manager for Connell Neurosurgical. He received a B.S. degree in Chemistry from the University of Richmond.

Neal Moszkowski has been a director of the Company since 2006. He previously served as a director of the Company from March 1999 to May 2005. He has been the Co-Chief Executive Officer of TowerBrook Capital Partners, LP, a private equity investment firm, since 2005. Prior to joining TowerBrook, Mr. Moszkowski was Managing Director and Co-Head of Soros Private Equity, the private equity investment business of Soros Fund Management LLC, where he served since August 1998. From August 1993 to August 1998, Mr. Moszkowski worked for Goldman, Sachs & Co. and affiliates, where he served as Vice President and Executive Director in the Principal Investment Area. Mr. Moszkowski also currently serves as a director of Wellcare Health Plans, Inc., Bluefly, Inc. and Spheris, Inc. as well as several privately-owned companies.

Ms. VanLent is currently Executive Vice President and Chief Financial Officer for Barrier Therapeutics, Inc. an emerging specialty pharmaceutical company in the field of dermatology. Prior to joining Barrier in May 2002, Ms. VanLent was a founder of The Technology Compass Group, LLC, a healthcare/technology consulting firm. From mid-1997 through October 2001, Ms. VanLent was with Sarnoff Corporation, a privately-held research and development company which creates and commercializes electronic, biomedical, and information technologies, where her last position held was Executive Vice President, Portfolio Management, overseeing creation of spin-off companies and patent and licensing activities. Ms. VanLent served as President of AMV Associates, an emerging growth healthcare consulting firm from March 1994 through August 1997. She currently serves as a director of a private fuel cell development company and a director and member of the audit committee for Integra Life Science Holdings. Ms. VanLent received a B.A. in Physics from Mount Holyoke College.

Mr. Holtz joined NUCRYST in May 2008 as Vice President and CFO, and in January 2009 assumed the additional role of Interim President and CEO. Before joining NUCRYST, Mr. Holtz served as a financial management consultant for various start-up companies, including Virium Pharmaceuticals, Inc. Previously he worked in various managerial roles of increasing importance at Integra LifeSciences Holdings Corporation from October 1993 through December 2006, most recently as Senior Vice President of Finance. While at Integra, Mr. Holtz oversaw Integra's European operations to support the transition of acquisitions in Europe and managed all worldwide financial reporting and accounting functions. Prior to Integra, he worked for Coopers & Lybrand LLP and Cono Leasing Corporation. Mr. Holtz received a B.S. in Business Administration with an emphasis on finance from Susquehanna University and is a Certified Public Accountant.

Former Senior Vice President and Treasurer, Time Warner Inc. Raymond G. Murphy has been a director of the Company since April 2009. Between 2004 and 2008, he was Senior Vice President & Treasurer of Time Warner Inc. Between 2001 and 2004, he was Vice President & Treasurer of Time Warner Inc. From 1999 until 2001, he was Senior Vice President & Treasurer of America Online, Inc. Between 1993 and 1999, he was Senior Vice President, Finance & Treasurer of Marriott International, Inc. Prior to Marriott, he held executive positions at Manor Care, Inc., Ryder System, Inc. and WR Grace & Company. Since 2005, he has been a member of the Finance Committee of The Advertising Council, Inc. and from 2007 until 2009, he served as Chair of such committee. Between 2004 and 2009, he served on the Board of Directors of The Advertising Council, Inc. and between 2007 and 2009, he served on its Executive Committee. He received a B.S. from Villanova University and an M.B.A. from Columbia University Graduate School of Business.